UroGen Pharma Ltd. (URGN)
20.90
-0.02
(-0.10%)
USD |
NASDAQ |
Feb 24, 14:59
UroGen Pharma Market Cap : 978.31M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.184B |
| Agenus, Inc. | 117.46M |
| Alnylam Pharmaceuticals, Inc. | 43.82B |
| Savara, Inc. | 1.156B |
| Arrowhead Pharmaceuticals, Inc. | 9.061B |
Market Cap Related Metrics
| PS Ratio | 10.30 |
| PEG Ratio | -0.5948 |
| Price | 20.90 |
| Earnings Yield | -16.57% |
| PEGY Ratio | -0.5948 |